Tag: MindMed - Page 11 - Psychedelic Alpha

Read more about the article MindMed Adds MDMA to Develop Next-Gen Psychedelic Therapies

MindMed Adds MDMA to Develop Next-Gen Psychedelic Therapies

Post published:May 27, 2020
Post category:Press Release

Read more about the article MindMed Closes Upsized Financing of $13.2m to Advance UHB Liechti Lab Collaboration for Next-Gen Psychedelic Inspired Medicines

MindMed Closes Upsized Financing of $13.2m to Advance UHB Liechti Lab Collaboration for Next-Gen Psychedelic Inspired Medicines

Post published:May 26, 2020
Post category:Press Release

Read more about the article MindMed Files Final Prospectus In Connection With Bought Deal Equity Financing

MindMed Files Final Prospectus In Connection With Bought Deal Equity Financing

Post published:May 22, 2020
Post category:Press Release

Read more about the article MindMed Reports First Quarter 2020 Results and Corporate Update

MindMed Reports First Quarter 2020 Results and Corporate Update

Post published:May 14, 2020
Post category:Press Release

Read more about the article MindMed Advances Phase 2 LSD Microdosing Trial For Adult ADHD, Appoints Principal Investigator

MindMed Advances Phase 2 LSD Microdosing Trial For Adult ADHD, Appoints Principal Investigator

Post published:May 11, 2020
Post category:Press Release

Read more about the article MindMed Files Preliminary Prospectus In Connection With Bought Deal Equity Financing

MindMed Files Preliminary Prospectus In Connection With Bought Deal Equity Financing

Post published:May 11, 2020
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.